A carregar...
Current Management of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors
The clinical outcomes and survival of tyrosine kinase inhibitor (TKI)-treated patients with chronic myeloid leukemia (CML) have been significantly improved. The aim of this editorial is to outline critical steps of TKI administration practices during the long-term clinical course of CML based on dat...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Galenos Publishing
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3878539/ https://ncbi.nlm.nih.gov/pubmed/24385803 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4274/Tjh.2013.0108 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|